BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 12.18
+0.23 (1.92%)
At close: Dec 5, 2025
BioSyent Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 137 | 128 | 108 | 85 | 104 | 101 | Upgrade
|
| Market Cap Growth | 6.03% | 17.76% | 28.05% | -18.50% | 2.59% | 22.26% | Upgrade
|
| Enterprise Value | 115 | 112 | 80 | 58 | 78 | 79 | Upgrade
|
| Last Close Price | 12.18 | 10.81 | 8.90 | 6.62 | 7.77 | 7.44 | Upgrade
|
| PE Ratio | 16.31 | 17.56 | 16.79 | 15.52 | 16.54 | 26.69 | Upgrade
|
| Forward PE | 14.33 | 14.52 | 17.23 | 13.86 | 18.77 | 21.67 | Upgrade
|
| PS Ratio | 3.25 | 3.65 | 3.43 | 3.03 | 3.63 | 4.54 | Upgrade
|
| PB Ratio | 3.44 | 3.65 | 3.12 | 2.54 | 3.29 | 3.78 | Upgrade
|
| P/TBV Ratio | 3.91 | 4.24 | 3.21 | 2.62 | 3.38 | 3.92 | Upgrade
|
| P/FCF Ratio | 16.93 | 14.80 | 21.71 | 17.28 | 22.64 | 14.72 | Upgrade
|
| P/OCF Ratio | 16.85 | 14.74 | 21.45 | 17.11 | 22.23 | 14.69 | Upgrade
|
| EV/Sales Ratio | 2.72 | 3.19 | 2.55 | 2.09 | 2.74 | 3.55 | Upgrade
|
| EV/EBITDA Ratio | 9.47 | 11.64 | 10.54 | 8.03 | 9.26 | 14.78 | Upgrade
|
| EV/EBIT Ratio | 10.06 | 12.17 | 10.76 | 8.36 | 9.58 | 15.77 | Upgrade
|
| EV/FCF Ratio | 14.15 | 12.94 | 16.10 | 11.90 | 17.08 | 11.53 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.11 | 0.16 | 0.19 | 0.18 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 0.11 | 0.12 | 0.24 | 0.28 | 0.34 | 0.25 | Upgrade
|
| Asset Turnover | 0.91 | 0.85 | 0.77 | 0.72 | 0.81 | 0.69 | Upgrade
|
| Inventory Turnover | 1.65 | 1.28 | 1.15 | 1.50 | 2.80 | 2.33 | Upgrade
|
| Quick Ratio | 4.18 | 3.49 | 5.36 | 5.63 | 7.49 | 5.33 | Upgrade
|
| Current Ratio | 5.06 | 4.53 | 6.48 | 6.49 | 8.24 | 5.79 | Upgrade
|
| Return on Equity (ROE) | 22.35% | 20.84% | 18.97% | 16.82% | 21.53% | 14.43% | Upgrade
|
| Return on Assets (ROA) | 15.28% | 13.85% | 11.39% | 11.24% | 14.46% | 9.74% | Upgrade
|
| Return on Capital (ROIC) | 17.99% | 15.94% | 13.20% | 12.86% | 16.60% | 11.20% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.00% | 25.50% | 20.80% | 20.10% | 24.80% | 17.70% | Upgrade
|
| Earnings Yield | 6.29% | 5.69% | 5.96% | 6.44% | 6.04% | 3.75% | Upgrade
|
| FCF Yield | 5.91% | 6.76% | 4.61% | 5.79% | 4.42% | 6.79% | Upgrade
|
| Dividend Yield | 1.64% | 1.66% | 1.80% | 0.60% | - | - | Upgrade
|
| Payout Ratio | 25.50% | 28.61% | 29.61% | 8.87% | - | - | Upgrade
|
| Buyback Yield / Dilution | 2.73% | 2.98% | 2.95% | 2.57% | 1.70% | 6.10% | Upgrade
|
| Total Shareholder Return | 4.40% | 4.64% | 4.75% | 3.17% | 1.70% | 6.10% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.